<DOC>
	<DOCNO>NCT02253485</DOCNO>
	<brief_summary>Mother-to-child transmission ( MTCT ) common route hepatitis B virus ( HBV ) infection . After give standard immunoprophylaxis , MTCT still occur infant bear HBsAg positive mother high HBV DNA load . The main purpose study evaluate efficacy method use block MTCT HBV infant born HBsAg positive mother high serum HBV DNA load .</brief_summary>
	<brief_title>Efficacy Antiviral Therapy Pregnancy Preventing Vertical Transmission HBV Mothers With High Viral Load</brief_title>
	<detailed_description>This study contain 600 patient compose group follow : ( ⅰ ) infant bear HBsAg positive mother high HBV DNA load delivery receive standard immunoprophylaxis ( injection HBIG 200IU birth plus HBV vaccine 0,1 6month ) ; ( ⅱ ) infant bear HBsAg positive mother high HBV DNA load delivery , base standard immunoprophylaxis receive addition injection HBIG 200IU 1 month birth ; ( ⅲ ) infant bear HBsAg positive high HBV DNA load mother treat antiviral therapy late pregnancy , receive standard immunoprophylaxis ; ( ⅳ ) infant bear HBsAg positive mother treat antiviral therapy entire pregnancy hepatitis receive standard immunoprophylaxis ; ( ⅴ ) infant bear HBsAg positive mother serum HBV DNA negative receive standard immunoprophylaxis .</detailed_description>
	<mesh_term>Telbivudine</mesh_term>
	<mesh_term>Antiviral Agents</mesh_term>
	<criteria>infant bear HBsAg positive mother HBsAg positive mother mother coinfected HIV HCV</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>7 Months</maximum_age>
	<verification_date>August 2012</verification_date>
	<keyword>Mother-to-child transmission</keyword>
</DOC>